ATE557082T1 - Sequenz positionen zur anpassung bei prrsv - Google Patents

Sequenz positionen zur anpassung bei prrsv

Info

Publication number: ATE557082T1
Authority: AT; Austria
Prior art keywords: amino acid; positions; arterivirus; specifically; amino acids
Prior art date: 2002-04-05

Application number

AT02076334T

Other languages

English (en)

Inventor

Rijn Petrus Antonius Van

Johanna Jacoba Maria Meulenberg

Michiel Kroese

Original Assignee

Boehringer Ingelheim Vetmed

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-05

Filing date

2002-04-05

Publication date

2012-05-15

2002-04-05 Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed

2012-05-15 Application granted granted Critical

2012-05-15 Publication of ATE557082T1 publication Critical patent/ATE557082T1/de

Links

241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 title abstract 4
125000003275 alpha amino acid group Chemical group 0.000 abstract 6
150000001413 amino acids Chemical group 0.000 abstract 6
238000000034 method Methods 0.000 abstract 4
241000700605 Viruses Species 0.000 abstract 3
241000867607 Chlorocebus sabaeus Species 0.000 abstract 2
101150034914 GP2a gene Proteins 0.000 abstract 2
SPEFJYZGXZENAF-UHFFFAOYSA-N N-cyclohexyl-1-(2,4-dichlorophenyl)-6-methyl-4H-indeno[1,2-c]pyrazole-3-carboxamide Chemical compound C=1C(C)=CC=C(C2=3)C=1CC=3C(C(=O)NC1CCCCC1)=NN2C1=CC=C(Cl)C=C1Cl SPEFJYZGXZENAF-UHFFFAOYSA-N 0.000 abstract 2
230000001018 virulence Effects 0.000 abstract 2
230000006978 adaptation Effects 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10061—Methods of inactivation or attenuation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10061—Methods of inactivation or attenuation
- C12N2770/10064—Methods of inactivation or attenuation by serial passage

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Oncology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT02076334T 2002-04-05 2002-04-05 Sequenz positionen zur anpassung bei prrsv ATE557082T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP02076334A EP1350840B1 (de)	2002-04-05	2002-04-05	Sequenz Positionen zur Anpassung bei PRRSV

Publications (1)

Publication Number	Publication Date
ATE557082T1 true ATE557082T1 (de)	2012-05-15

Family

ID=27838115

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02076334T ATE557082T1 (de)	2002-04-05	2002-04-05	Sequenz positionen zur anpassung bei prrsv

Country Status (5)

Country	Link
US (1)	US7312030B2 (de)
EP (1)	EP1350840B1 (de)
JP (1)	JP4477307B2 (de)
AT (1)	ATE557082T1 (de)
CA (1)	CA2424400C (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040224327A1 (en) *	1996-10-30	2004-11-11	Meulenberg Johanna Jacoba Maria	Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof
EP0839912A1 (de) *	1996-10-30	1998-05-06	Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo)	Ansteckende Klone von RNA-Viren und darauf basierende Impfstoffe und diagnostisches Verfahren
EP1157121B1 (de) *	1999-03-08	2013-04-24	Boehringer Ingelheim Vetmedica GmbH	Prrsv replikon
ES2388909T3 (es) *	1999-04-22	2012-10-19	The United States Of America, As Represented Bythe Secretary Of Agriculture	Vacuna contra el virus del síndrome respiratorio y reproductivo porcino basada en aislado JA-142 aislada
AU2005265142A1 (en) *	2004-06-18	2006-01-26	Regents Of The University Of Minnesota	Identifying virally infected and vaccinated organisms
US7632636B2 (en) *	2004-09-21	2009-12-15	Boehringer Ingelheim Vetmedica, Inc.	Porcine reproductive and respiratory syndrome isolates and methods of use
BRPI0518353A2 (pt) *	2004-11-19	2008-11-18	Intervet Int Bv	composiÇço imunogÉnica, vÍrus de sÍndrome respiratària e reprodutiva porcina atenuado, e, mÉtodo para proteger um suÍno contra a sÍndrome respiratària e reprodutiva porcina
MX2007015849A (es)	2005-06-24	2008-02-22	Univ Minnesota	Virus del sindrome respiratorio y reproductivo porcino, clones infecciosos, mutantes de los mismos, y metodos de uso.
CA2620667A1 (en) *	2005-08-30	2007-04-12	Board Of Regents Of The University Of Nebraska	Methods and compositions for vaccination of animals with prrsv antigens with improved immunogenicity
US8084594B2 (en) *	2007-07-13	2011-12-27	The United States Of America As Represented By The Secretary Of Agriculture	H2N3 influenza A viruses and methods of use
BRPI0917887A2 (pt) *	2008-08-25	2019-09-03	Boehringer Ingelheim Vetmedica Inc	vacina contra síndrome reprodutiva e respiratória suína altamente patogênica (hp pprs)
TWI627281B (zh) *	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
EP2675475B1 (de)	2011-02-17	2015-07-01	Boehringer Ingelheim Vetmedica GmbH	Neuer europäischer prrsv-stamm
ES2553879T3 (es)	2011-02-17	2015-12-14	Boehringer Ingelheim Vetmedica Gmbh	Procedimiento para la producción a escala comercial de PRRSV
EP2737059A1 (de)	2011-07-29	2014-06-04	Boehringer Ingelheim Vetmedica GmbH	Neuartiges prrs-virus zur induktion von interferon des typs i in empfindlichen zellen
US9187731B2 (en)	2011-07-29	2015-11-17	Boehringer Ingelheim Vetmedica Gmbh	PRRS virus inducing type I interferon in susceptible cells
WO2014150822A2 (en)	2013-03-15	2014-09-25	Boehringer Ingelheim Vetmedica, Inc.	Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
US10010601B2 (en)	2013-12-20	2018-07-03	Boehringer Ingelheim Vetmedica Gmbh	PRRS virus variant, European PRRS virus cDNA clone, and uses thereof

2002
- 2002-04-05 EP EP02076334A patent/EP1350840B1/de not_active Expired - Lifetime
- 2002-04-05 AT AT02076334T patent/ATE557082T1/de active
2003
- 2003-04-03 CA CA2424400A patent/CA2424400C/en not_active Expired - Fee Related
- 2003-04-04 US US10/407,822 patent/US7312030B2/en not_active Expired - Lifetime
- 2003-04-04 JP JP2003102066A patent/JP4477307B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2424400A1 (en)	2003-10-05
EP1350840B1 (de)	2012-05-09
US20030219732A1 (en)	2003-11-27
CA2424400C (en)	2012-08-21
EP1350840A1 (de)	2003-10-08
JP4477307B2 (ja)	2010-06-09
US7312030B2 (en)	2007-12-25
JP2004121220A (ja)	2004-04-22

Publication	Publication Date	Title
ATE557082T1 (de)	2012-05-15	Sequenz positionen zur anpassung bei prrsv
NO20043419L (no)	2004-10-18	Nytt cytokin, zcytor17-ligand
SG171577A1 (en)	2011-06-29	Methods for producing yeast-based vaccines
DK1680509T3 (da)	2020-03-02	Fremgangsmåde til fremstilling af carbonhydrider og oxygenholdige forbindelser fra biomasse der inkluderer fermentation med tilsætning af aminosyre (leu, ile, val)
ATE425136T1 (de)	2009-03-15	Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
CY1110964T1 (el)	2015-06-11	Μεθοδος παραγωγης εμβολιων μεγαλης κλιμακας
NO20014364D0 (no)	2001-09-07	Ny cytokin-zalphall-ligand
ATE501264T1 (de)	2011-03-15	Enzymatische verfahren zur herstellung 4- substituierter 3-hydroxybuttersäure-derivate
HRP20040320B1 (hr)	2012-11-30	POSTUPAK ZA PRIPRAVU HEKSAHIDRO-FURO[2,3-b]FURAN-3-OLA
NO20074895L (no)	2007-11-26	Isoksazolin derivat og ny fremgangsmate for fremstilling derav
DE50311220D1 (de)	2009-04-09	Verfahren zur herstellung von hochreinem methyl-tert.-butylether
HUP0000992A2 (hu)	2000-11-28	Sejttenyészetben szaporodni képes, géntechnológiailag módosított, fertőző nyálkatömlő-betegséget okozó vírus (IBDV) mutánsai
DE60042035D1 (de)	2009-05-28	Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen
EA200400195A1 (ru)	2004-06-24	Способ репродукции вируса
WO2006034093A3 (en)	2006-07-13	3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
BRPI0410861A (pt)	2006-05-23	métodos e composições para a produção de aminoácidos
ITMI20022076A1 (it)	2004-04-02	Sali di intermedi del cefdinir.
NO20040388L (no)	2004-01-29	Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
EA200801109A1 (ru)	2008-10-30	Состав для литья и способ его получения
WO2006021559A3 (de)	2006-08-17	Verfahren zur herstellung von tiotropiumsalzen und silicium-derivate als zwischenprodukte
DK1127886T3 (da)	2003-09-01	Syntese af 3,6-dialkyl-5,6-dihydro-4-hydroxy-2H-pyran-2-on
ATE403005T1 (de)	2008-08-15	Rekombinantes mva und verfahren zur erzeugung davon
ATE391115T1 (de)	2008-04-15	Verfahren zur herstellung von diketenacetalen
UA100849C2 (ru)	2013-02-11	Способ репликации вируса гриппа в культуре
DK1501838T3 (da)	2007-08-20	Fremgangsmåde til fremstilling af clopidogrel